+91-22-48913909
Table of Contents
- മ്യൂച്വൽ ഫണ്ടുകളിൽ ഓൺലൈനിൽ എങ്ങനെ നിക്ഷേപിക്കാം?
- 2022 ലെ മികച്ച 11 മികച്ച മ്യൂച്വൽ ഫണ്ടുകൾ
Top 11 Funds
- SBI Magnum Equity ESG Fund
- HDFC Long Term Advantage Fund
- IDBI Nifty Index Fund
- IDBI Equity Advantage Fund
- IDBI India Top 100 Equity Fund
- Principal Emerging Bluechip Fund
- L&T Equity Fund
- SBI Healthcare Opportunities Fund
- IDBI Diversified Equity Fund
- SBI Technology Opportunities Fund
- TATA India Pharma & Healthcare Fund
2022-ലെ മികച്ച പ്രകടനം കാഴ്ചവെക്കുന്ന മ്യൂച്വൽ ഫണ്ടുകൾ
ചുവടെയുള്ള മാനദണ്ഡങ്ങൾ അടിസ്ഥാനമാക്കി ഞങ്ങൾ തിരഞ്ഞെടുത്തുമികച്ച പ്രകടനം നടത്തുന്ന മ്യൂച്വൽ ഫണ്ടുകൾ November, 2022. ഞങ്ങൾ ഫിൽട്ടർ ചെയ്‌ത ഫണ്ടുകൾ ഏറ്റവും കുറഞ്ഞത്
100 കോടിഎല്ലാ വിഭാഗങ്ങളിൽ നിന്നും മാനേജ്‌മെന്റിന് കീഴിലുള്ള ആസ്തികൾ.
Talk to our investment specialist
മാനദണ്ഡം
- AUM> 100 കോടി
- ഫണ്ടിന്റെ പ്രായം > 1 വർഷം
- എല്ലാ വിഭാഗങ്ങളിൽ നിന്നുമുള്ള ഫണ്ടുകൾ
- 1 മാസത്തെ റിട്ടേണുകളിൽ ക്രമീകരിച്ചു.
- ഫണ്ടുകളുടെ വിഭാഗങ്ങൾ
- ഇക്വിറ്റി
- കടം
- ഹൈബ്രിഡ്
- സ്വർണ്ണം
- ആഗോള ഫണ്ട്
മ്യൂച്വൽ ഫണ്ടുകളിൽ ഓൺലൈനിൽ എങ്ങനെ നിക്ഷേപിക്കാം?
Fincash.com-ൽ ആജീവനാന്ത സൗജന്യ നിക്ഷേപ അക്കൗണ്ട് തുറക്കുക.
നിങ്ങളുടെ രജിസ്ട്രേഷനും KYC പ്രക്രിയയും പൂർത്തിയാക്കുക
രേഖകൾ അപ്‌ലോഡ് ചെയ്യുക (പാൻ, ആധാർ മുതലായവ).കൂടാതെ, നിങ്ങൾ നിക്ഷേപിക്കാൻ തയ്യാറാണ്!
2022 ലെ മികച്ച 11 മികച്ച മ്യൂച്വൽ ഫണ്ടുകൾ
Fund NAV Net Assets (Cr) Min Investment Min SIP Investment 1 MO (%) 3 MO (%) 6 MO (%) 1 YR (%) 3 YR (%) 5 YR (%) 2023 (%) SBI Magnum Equity ESG Fund Growth ₹233.262
↓ -1.37 ₹5,806 1,000 500 13.4 -3.6 -1.5 15.9 11.1 15.4 12.1 HDFC Long Term Advantage Fund Growth ₹595.168
↑ 0.28 ₹1,318 500 500 4.4 1.2 15.4 35.5 20.6 17.4 IDBI Nifty Index Fund Growth ₹36.2111
↓ -0.02 ₹208 5,000 500 3.7 9.1 11.9 16.2 20.3 11.7 IDBI Equity Advantage Fund Growth ₹43.39
↑ 0.04 ₹485 500 500 3.1 9.7 15.1 16.9 20.8 10 IDBI India Top 100 Equity Fund Growth ₹44.16
↑ 0.05 ₹655 5,000 500 3 9.2 12.5 15.4 21.9 12.6 Principal Emerging Bluechip Fund Growth ₹183.316
↑ 2.03 ₹3,124 5,000 100 2.9 2.9 13.6 38.9 21.9 19.2 L&T Equity Fund Growth ₹124.542
↑ 0.00 ₹2,884 5,000 500 2.7 3.3 15.6 2.2 14.3 9 SBI Healthcare Opportunities Fund Growth ₹440.298
↓ -0.26 ₹3,460 5,000 500 2.6 5.6 22.4 39.5 23.1 29.7 42.2 IDBI Diversified Equity Fund Growth ₹37.99
↑ 0.14 ₹382 5,000 500 2.4 10.2 13.2 13.5 22.7 12 SBI Technology Opportunities Fund Growth ₹227.981
↓ -1.44 ₹4,586 5,000 500 2.2 5.7 18.4 34.3 11.3 27.3 30.1 TATA India Pharma & Healthcare Fund Growth ₹31.4764
↓ -0.33 ₹1,214 5,000 150 2.2 2.1 15.8 35.2 21.1 27.9 40.4 Note: Returns up to 1 year are on absolute basis & more than 1 year are on CAGR basis. as on 3 Jan 25
*ഇതിന്റെ ലിസ്റ്റ് ചുവടെയുണ്ട്മുൻനിര മ്യൂച്വൽ ഫണ്ടുകൾ 2022-ലെ സി.എംആസ്തി >= 100 കോടി
(Erstwhile SBI Magnum Equity Fund) To provide the investor long-term capital appreciation by investing in high growth companies along with the liquidity of an open-ended scheme through investments primarily in equities and the balance in debt and money market instruments. SBI Magnum Equity ESG Fund is a Equity - Sectoral fund was launched on 27 Nov 06. It is a fund with Moderately High risk and has given a Below is the key information for SBI Magnum Equity ESG Fund Returns up to 1 year are on To generate long term capital appreciation from a portfolio that is predominantly in equity and equity related instruments HDFC Long Term Advantage Fund is a Equity - ELSS fund was launched on 2 Jan 01. It is a fund with Moderately High risk and has given a Below is the key information for HDFC Long Term Advantage Fund Returns up to 1 year are on The investment objective of the scheme is to invest in the stocks and equity related instruments comprising the S&P CNX Nifty Index in the same weights as these stocks represented in the Index with the intent to replicate the performance of the Total Returns Index of S&P CNX Nifty index. The scheme will adopt a passive investment strategy and will seek to achieve the investment objective by minimizing the tracking error between the S&P CNX Nifty index (Total Returns Index) and the scheme. IDBI Nifty Index Fund is a Others - Index Fund fund was launched on 25 Jun 10. It is a fund with Moderately High risk and has given a Below is the key information for IDBI Nifty Index Fund Returns up to 1 year are on The Scheme will seek to invest predominantly in a diversified portfolio of equity and equity related instruments with the objective to provide investors with opportunities for capital appreciation and income along with the benefit of income-tax deduction(under section 80C of the Income-tax Act, 1961) on their investments. Investments in this scheme would be subject to a statutory lock-in of 3 years from the date of allotment to be eligible for income-tax benefits under Section 80C. There can be no assurance that the investment objective under the scheme will be realized. IDBI Equity Advantage Fund is a Equity - ELSS fund was launched on 10 Sep 13. It is a fund with Moderately High risk and has given a Below is the key information for IDBI Equity Advantage Fund Returns up to 1 year are on The Investment objective of the Scheme is to provide investors with the opportunities for long-term capital appreciation by investing predominantly in Equity and Equity related Instruments of Large Cap companies. However
there can be no assurance that the investment objective under the Scheme will be realized. IDBI India Top 100 Equity Fund is a Equity - Large Cap fund was launched on 15 May 12. It is a fund with Moderately High risk and has given a Below is the key information for IDBI India Top 100 Equity Fund Returns up to 1 year are on The primary objective of the Scheme is to achieve long-term capital appreciation by investing in equity & equity related instruments of mid cap & small cap companies. Principal Emerging Bluechip Fund is a Equity - Large & Mid Cap fund was launched on 12 Nov 08. It is a fund with Moderately High risk and has given a Below is the key information for Principal Emerging Bluechip Fund Returns up to 1 year are on To generate long-term capital growth from a diversified portfolio of predominantly equity and equity-related securities. L&T Equity Fund is a Equity - Multi Cap fund was launched on 16 May 05. It is a fund with Moderately High risk and has given a Below is the key information for L&T Equity Fund Returns up to 1 year are on (Erstwhile SBI Pharma Fund) To provide the investors maximum growth opportunity through equity
investments in stocks of growth oriented sectors of the economy. SBI Healthcare Opportunities Fund is a Equity - Sectoral fund was launched on 31 Dec 04. It is a fund with High risk and has given a Below is the key information for SBI Healthcare Opportunities Fund Returns up to 1 year are on The Investment objective of the Scheme is to provide investors with the opportunities for long-term capital appreciation by investing in a diversified portfolio of Equity and Equity related Instruments across market capitalization. However there can be no assurance that the investment objective under the Scheme will be realized IDBI Diversified Equity Fund is a Equity - Multi Cap fund was launched on 28 Mar 14. It is a fund with Moderately High risk and has given a Below is the key information for IDBI Diversified Equity Fund Returns up to 1 year are on (Erstwhile SBI IT Fund) To provide the investors maximum growth opportunity through equity
investments in stocks of growth oriented sectors of the economy. SBI Technology Opportunities Fund is a Equity - Sectoral fund was launched on 9 Jan 13. It is a fund with High risk and has given a Below is the key information for SBI Technology Opportunities Fund Returns up to 1 year are on The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved.The Scheme does not assure or guarantee any returns. TATA India Pharma & Healthcare Fund is a Equity - Sectoral fund was launched on 28 Dec 15. It is a fund with High risk and has given a Below is the key information for TATA India Pharma & Healthcare Fund Returns up to 1 year are on 1. SBI Magnum Equity ESG Fund
CAGR/Annualized return of 9.7% since its launch. Ranked 47 in Sectoral category. Return for 2024 was 12.1% , 2023 was 24.6% and 2022 was -2.3% . SBI Magnum Equity ESG Fund
Growth Launch Date 27 Nov 06 NAV (03 Jan 25) ₹233.262 ↓ -1.37 (-0.58 %) Net Assets (Cr) ₹5,806 on 30 Nov 24 Category Equity - Sectoral AMC SBI Funds Management Private Limited Rating ☆☆☆ Risk Moderately High Expense Ratio 1.97 Sharpe Ratio 1.29 Information Ratio 0.05 Alpha Ratio 2.44 Min Investment 1,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Dec 19 ₹10,000 31 Dec 20 ₹11,354 31 Dec 21 ₹14,795 31 Dec 22 ₹14,451 31 Dec 23 ₹18,012 31 Dec 24 ₹20,198 Returns for SBI Magnum Equity ESG Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 3 Jan 25 Duration Returns 1 Month 13.4% 3 Month -3.6% 6 Month -1.5% 1 Year 15.9% 3 Year 11.1% 5 Year 15.4% 10 Year 15 Year Since launch 9.7% Historical performance (Yearly) on absolute basis
Year Returns 2023 12.1% 2022 24.6% 2021 -2.3% 2020 30.3% 2019 13.5% 2018 14.8% 2017 3.3% 2016 24.1% 2015 4.5% 2014 2.4% Fund Manager information for SBI Magnum Equity ESG Fund
Name Since Tenure Rohit Shimpi 1 Jan 22 3 Yr. Pradeep Kesavan 1 Dec 23 1.09 Yr. Data below for SBI Magnum Equity ESG Fund as on 30 Nov 24
Equity Sector Allocation
Sector Value Financial Services 34.21% Technology 21.31% Consumer Cyclical 15.01% Industrials 12% Basic Materials 5.28% Health Care 3.95% Energy 2.58% Consumer Defensive 2.32% Utility 1.7% Asset Allocation
Asset Class Value Cash 1.63% Equity 98.37% Top Securities Holdings / Portfolio
Name Holding Value Quantity HDFC Bank Ltd (Financial Services)
Equity, Since 31 Jul 09 | HDFCBANK9% ₹524 Cr 2,917,400 Infosys Ltd (Technology)
Equity, Since 28 Feb 03 | INFY9% ₹502 Cr 2,701,000 ICICI Bank Ltd (Financial Services)
Equity, Since 30 Sep 09 | ICICIBANK8% ₹453 Cr 3,485,000 Tata Consultancy Services Ltd (Technology)
Equity, Since 30 Nov 17 | TCS5% ₹278 Cr 651,034 Larsen & Toubro Ltd (Industrials)
Equity, Since 30 Jun 16 | LT5% ₹273 Cr 731,709 Axis Bank Ltd (Financial Services)
Equity, Since 31 May 18 | AXISBANK4% ₹260 Cr 2,290,000 Kotak Mahindra Bank Ltd (Financial Services)
Equity, Since 31 Aug 22 | KOTAKBANK4% ₹218 Cr 1,235,000 State Bank of India (Financial Services)
Equity, Since 28 Feb 09 | SBIN4% ₹204 Cr 2,430,000 UltraTech Cement Ltd (Basic Materials)
Equity, Since 31 Jul 19 | ULTRACEMCO3% ₹196 Cr 175,000 Maruti Suzuki India Ltd (Consumer Cyclical)
Equity, Since 31 Dec 20 | MARUTI3% ₹181 Cr 163,000 2. HDFC Long Term Advantage Fund
CAGR/Annualized return of 21.4% since its launch. Ranked 23 in ELSS category. . HDFC Long Term Advantage Fund
Growth Launch Date 2 Jan 01 NAV (14 Jan 22) ₹595.168 ↑ 0.28 (0.05 %) Net Assets (Cr) ₹1,318 on 30 Nov 21 Category Equity - ELSS AMC HDFC Asset Management Company Limited Rating ☆☆☆ Risk Moderately High Expense Ratio 2.25 Sharpe Ratio 2.27 Information Ratio -0.15 Alpha Ratio 1.75 Min Investment 500 Min SIP Investment 500 Exit Load NIL Growth of 10,000 investment over the years.
Date Value 31 Dec 19 ₹10,000 31 Dec 20 ₹11,150 31 Dec 21 ₹15,037
Purchase not allowed Returns for HDFC Long Term Advantage Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 3 Jan 25 Duration Returns 1 Month 4.4% 3 Month 1.2% 6 Month 15.4% 1 Year 35.5% 3 Year 20.6% 5 Year 17.4% 10 Year 15 Year Since launch 21.4% Historical performance (Yearly) on absolute basis
Year Returns 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 Fund Manager information for HDFC Long Term Advantage Fund
Name Since Tenure Data below for HDFC Long Term Advantage Fund as on 30 Nov 21
Equity Sector Allocation
Sector Value Asset Allocation
Asset Class Value Top Securities Holdings / Portfolio
Name Holding Value Quantity 3. IDBI Nifty Index Fund
CAGR/Annualized return of 10.3% since its launch. Ranked 83 in Index Fund category. . IDBI Nifty Index Fund
Growth Launch Date 25 Jun 10 NAV (28 Jul 23) ₹36.2111 ↓ -0.02 (-0.06 %) Net Assets (Cr) ₹208 on 30 Jun 23 Category Others - Index Fund AMC IDBI Asset Management Limited Rating ☆ Risk Moderately High Expense Ratio 0.9 Sharpe Ratio 1.04 Information Ratio -3.93 Alpha Ratio -1.03 Min Investment 5,000 Min SIP Investment 500 Exit Load NIL Growth of 10,000 investment over the years.
Date Value 31 Dec 19 ₹10,000 31 Dec 20 ₹11,465 31 Dec 21 ₹14,158 31 Dec 22 ₹14,825 Returns for IDBI Nifty Index Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 3 Jan 25 Duration Returns 1 Month 3.7% 3 Month 9.1% 6 Month 11.9% 1 Year 16.2% 3 Year 20.3% 5 Year 11.7% 10 Year 15 Year Since launch 10.3% Historical performance (Yearly) on absolute basis
Year Returns 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 Fund Manager information for IDBI Nifty Index Fund
Name Since Tenure Data below for IDBI Nifty Index Fund as on 30 Jun 23
Asset Allocation
Asset Class Value Top Securities Holdings / Portfolio
Name Holding Value Quantity 4. IDBI Equity Advantage Fund
CAGR/Annualized return of 16% since its launch. Ranked 21 in ELSS category. . IDBI Equity Advantage Fund
Growth Launch Date 10 Sep 13 NAV (28 Jul 23) ₹43.39 ↑ 0.04 (0.09 %) Net Assets (Cr) ₹485 on 30 Jun 23 Category Equity - ELSS AMC IDBI Asset Management Limited Rating ☆☆☆ Risk Moderately High Expense Ratio 2.39 Sharpe Ratio 1.21 Information Ratio -1.13 Alpha Ratio 1.78 Min Investment 500 Min SIP Investment 500 Exit Load NIL Growth of 10,000 investment over the years.
Date Value 31 Dec 19 ₹10,000 31 Dec 20 ₹10,837 31 Dec 21 ₹13,609 31 Dec 22 ₹13,903 Returns for IDBI Equity Advantage Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 3 Jan 25 Duration Returns 1 Month 3.1% 3 Month 9.7% 6 Month 15.1% 1 Year 16.9% 3 Year 20.8% 5 Year 10% 10 Year 15 Year Since launch 16% Historical performance (Yearly) on absolute basis
Year Returns 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 Fund Manager information for IDBI Equity Advantage Fund
Name Since Tenure Data below for IDBI Equity Advantage Fund as on 30 Jun 23
Equity Sector Allocation
Sector Value Asset Allocation
Asset Class Value Top Securities Holdings / Portfolio
Name Holding Value Quantity 5. IDBI India Top 100 Equity Fund
CAGR/Annualized return of 14.2% since its launch. Ranked 45 in Large Cap category. . IDBI India Top 100 Equity Fund
Growth Launch Date 15 May 12 NAV (28 Jul 23) ₹44.16 ↑ 0.05 (0.11 %) Net Assets (Cr) ₹655 on 30 Jun 23 Category Equity - Large Cap AMC IDBI Asset Management Limited Rating ☆☆☆ Risk Moderately High Expense Ratio 2.47 Sharpe Ratio 1.09 Information Ratio 0.14 Alpha Ratio 2.11 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Dec 19 ₹10,000 31 Dec 20 ₹11,643 31 Dec 21 ₹15,281 31 Dec 22 ₹15,730 Returns for IDBI India Top 100 Equity Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 3 Jan 25 Duration Returns 1 Month 3% 3 Month 9.2% 6 Month 12.5% 1 Year 15.4% 3 Year 21.9% 5 Year 12.6% 10 Year 15 Year Since launch 14.2% Historical performance (Yearly) on absolute basis
Year Returns 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 Fund Manager information for IDBI India Top 100 Equity Fund
Name Since Tenure Data below for IDBI India Top 100 Equity Fund as on 30 Jun 23
Equity Sector Allocation
Sector Value Asset Allocation
Asset Class Value Top Securities Holdings / Portfolio
Name Holding Value Quantity 6. Principal Emerging Bluechip Fund
CAGR/Annualized return of 24.8% since its launch. Ranked 1 in Large & Mid Cap category. . Principal Emerging Bluechip Fund
Growth Launch Date 12 Nov 08 NAV (31 Dec 21) ₹183.316 ↑ 2.03 (1.12 %) Net Assets (Cr) ₹3,124 on 30 Nov 21 Category Equity - Large & Mid Cap AMC Principal Pnb Asset Mgmt. Co. Priv. Ltd. Rating ☆☆☆☆☆ Risk Moderately High Expense Ratio 2.08 Sharpe Ratio 2.74 Information Ratio 0.22 Alpha Ratio 2.18 Min Investment 5,000 Min SIP Investment 100 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Dec 19 ₹10,000 31 Dec 20 ₹12,230 Returns for Principal Emerging Bluechip Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 3 Jan 25 Duration Returns 1 Month 2.9% 3 Month 2.9% 6 Month 13.6% 1 Year 38.9% 3 Year 21.9% 5 Year 19.2% 10 Year 15 Year Since launch 24.8% Historical performance (Yearly) on absolute basis
Year Returns 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 Fund Manager information for Principal Emerging Bluechip Fund
Name Since Tenure Data below for Principal Emerging Bluechip Fund as on 30 Nov 21
Equity Sector Allocation
Sector Value Asset Allocation
Asset Class Value Top Securities Holdings / Portfolio
Name Holding Value Quantity 7. L&T Equity Fund
CAGR/Annualized return of 15.5% since its launch. Ranked 25 in Multi Cap category. . L&T Equity Fund
Growth Launch Date 16 May 05 NAV (25 Nov 22) ₹124.542 ↑ 0.00 (0.00 %) Net Assets (Cr) ₹2,884 on 31 Oct 22 Category Equity - Multi Cap AMC L&T Investment Management Ltd Rating ☆☆☆☆ Risk Moderately High Expense Ratio 2.07 Sharpe Ratio -0.16 Information Ratio -1.29 Alpha Ratio -2.7 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Dec 19 ₹10,000 31 Dec 20 ₹11,316 31 Dec 21 ₹14,297 Returns for L&T Equity Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 3 Jan 25 Duration Returns 1 Month 2.7% 3 Month 3.3% 6 Month 15.6% 1 Year 2.2% 3 Year 14.3% 5 Year 9% 10 Year 15 Year Since launch 15.5% Historical performance (Yearly) on absolute basis
Year Returns 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 Fund Manager information for L&T Equity Fund
Name Since Tenure Data below for L&T Equity Fund as on 31 Oct 22
Equity Sector Allocation
Sector Value Asset Allocation
Asset Class Value Top Securities Holdings / Portfolio
Name Holding Value Quantity 8. SBI Healthcare Opportunities Fund
CAGR/Annualized return of 16.1% since its launch. Ranked 34 in Sectoral category. Return for 2024 was 42.2% , 2023 was 38.2% and 2022 was -6% . SBI Healthcare Opportunities Fund
Growth Launch Date 31 Dec 04 NAV (03 Jan 25) ₹440.298 ↓ -0.26 (-0.06 %) Net Assets (Cr) ₹3,460 on 30 Nov 24 Category Equity - Sectoral AMC SBI Funds Management Private Limited Rating ☆☆ Risk High Expense Ratio 2.09 Sharpe Ratio 2.85 Information Ratio 0.75 Alpha Ratio 5.08 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-15 Days (0.5%),15 Days and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Dec 19 ₹10,000 31 Dec 20 ₹16,583 31 Dec 21 ₹19,925 31 Dec 22 ₹18,725 31 Dec 23 ₹25,885 31 Dec 24 ₹36,814 Returns for SBI Healthcare Opportunities Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 3 Jan 25 Duration Returns 1 Month 2.6% 3 Month 5.6% 6 Month 22.4% 1 Year 39.5% 3 Year 23.1% 5 Year 29.7% 10 Year 15 Year Since launch 16.1% Historical performance (Yearly) on absolute basis
Year Returns 2023 42.2% 2022 38.2% 2021 -6% 2020 20.1% 2019 65.8% 2018 -0.5% 2017 -9.9% 2016 2.1% 2015 -14% 2014 27.1% Fund Manager information for SBI Healthcare Opportunities Fund
Name Since Tenure Tanmaya Desai 1 Jun 11 13.6 Yr. Pradeep Kesavan 31 Dec 23 1.01 Yr. Data below for SBI Healthcare Opportunities Fund as on 30 Nov 24
Equity Sector Allocation
Sector Value Health Care 89.92% Basic Materials 6.58% Asset Allocation
Asset Class Value Cash 3.5% Equity 96.5% Top Securities Holdings / Portfolio
Name Holding Value Quantity Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Dec 17 | SUNPHARMA13% ₹445 Cr 2,500,000
↑ 100,000 Divi's Laboratories Ltd (Healthcare)
Equity, Since 31 Mar 12 | DIVISLAB6% ₹222 Cr 360,000 Cipla Ltd (Healthcare)
Equity, Since 31 Aug 16 | CIPLA6% ₹196 Cr 1,280,000
↑ 280,000 Max Healthcare Institute Ltd Ordinary Shares (Healthcare)
Equity, Since 31 Mar 21 | MAXHEALTH6% ₹196 Cr 2,000,000
↓ -100,000 Lupin Ltd (Healthcare)
Equity, Since 31 Aug 23 | LUPIN5% ₹164 Cr 800,000 Lonza Group Ltd ADR (Healthcare)
Equity, Since 31 Jan 24 | LZAGY4% ₹152 Cr 300,000 Poly Medicure Ltd (Healthcare)
Equity, Since 31 Aug 24 | POLYMED4% ₹139 Cr 500,000
↓ -140,000 Krishna Institute of Medical Sciences Ltd (Healthcare)
Equity, Since 30 Nov 22 | 5433084% ₹130 Cr 2,200,000
↓ -300,000 Jupiter Life Line Hospitals Ltd (Healthcare)
Equity, Since 31 Aug 23 | JLHL4% ₹126 Cr 832,871
↓ -67,129 Aether Industries Ltd (Basic Materials)
Equity, Since 31 May 22 | 5435343% ₹115 Cr 1,400,000 9. IDBI Diversified Equity Fund
CAGR/Annualized return of 15.4% since its launch. Ranked 56 in Multi Cap category. . IDBI Diversified Equity Fund
Growth Launch Date 28 Mar 14 NAV (28 Jul 23) ₹37.99 ↑ 0.14 (0.37 %) Net Assets (Cr) ₹382 on 30 Jun 23 Category Equity - Multi Cap AMC IDBI Asset Management Limited Rating ☆☆ Risk Moderately High Expense Ratio 2.46 Sharpe Ratio 1.01 Information Ratio -0.53 Alpha Ratio -1.07 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Dec 19 ₹10,000 31 Dec 20 ₹11,618 31 Dec 21 ₹15,872 31 Dec 22 ₹15,696 Returns for IDBI Diversified Equity Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 3 Jan 25 Duration Returns 1 Month 2.4% 3 Month 10.2% 6 Month 13.2% 1 Year 13.5% 3 Year 22.7% 5 Year 12% 10 Year 15 Year Since launch 15.4% Historical performance (Yearly) on absolute basis
Year Returns 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 Fund Manager information for IDBI Diversified Equity Fund
Name Since Tenure Data below for IDBI Diversified Equity Fund as on 30 Jun 23
Equity Sector Allocation
Sector Value Asset Allocation
Asset Class Value Top Securities Holdings / Portfolio
Name Holding Value Quantity 10. SBI Technology Opportunities Fund
CAGR/Annualized return of 21.1% since its launch. Ranked 42 in Sectoral category. Return for 2024 was 30.1% , 2023 was 24.8% and 2022 was -15.5% . SBI Technology Opportunities Fund
Growth Launch Date 9 Jan 13 NAV (03 Jan 25) ₹227.981 ↓ -1.44 (-0.63 %) Net Assets (Cr) ₹4,586 on 30 Nov 24 Category Equity - Sectoral AMC SBI Funds Management Private Limited Rating ☆ Risk High Expense Ratio 1.99 Sharpe Ratio 1.42 Information Ratio 0.39 Alpha Ratio 2.51 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-15 Days (0.5%),15 Days and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Dec 19 ₹10,000 31 Dec 20 ₹14,734 31 Dec 21 ₹24,519 31 Dec 22 ₹20,728 31 Dec 23 ₹25,874 31 Dec 24 ₹33,650 Returns for SBI Technology Opportunities Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 3 Jan 25 Duration Returns 1 Month 2.2% 3 Month 5.7% 6 Month 18.4% 1 Year 34.3% 3 Year 11.3% 5 Year 27.3% 10 Year 15 Year Since launch 21.1% Historical performance (Yearly) on absolute basis
Year Returns 2023 30.1% 2022 24.8% 2021 -15.5% 2020 66.4% 2019 47.3% 2018 12.2% 2017 17.1% 2016 13% 2015 -3.3% 2014 2.4% Fund Manager information for SBI Technology Opportunities Fund
Name Since Tenure Pradeep Kesavan 1 Apr 24 0.75 Yr. Vivek Gedda 1 Apr 24 0.75 Yr. Data below for SBI Technology Opportunities Fund as on 30 Nov 24
Equity Sector Allocation
Sector Value Technology 57.69% Communication Services 24.5% Consumer Cyclical 6.56% Financial Services 2.89% Industrials 2.12% Consumer Defensive 1.12% Health Care 0.71% Asset Allocation
Asset Class Value Cash 1.65% Equity 98.35% Top Securities Holdings / Portfolio
Name Holding Value Quantity Infosys Ltd (Technology)
Equity, Since 31 Jan 03 | INFY24% ₹1,115 Cr 6,000,000 Bharti Airtel Ltd (Communication Services)
Equity, Since 31 May 18 | BHARTIARTL10% ₹472 Cr 2,900,000 Firstsource Solutions Ltd (Technology)
Equity, Since 31 Mar 23 | FSL6% ₹280 Cr 7,645,887 Coforge Ltd (Technology)
Equity, Since 31 Aug 23 | COFORGE6% ₹264 Cr 304,454 Tata Consultancy Services Ltd (Technology)
Equity, Since 30 Apr 06 | TCS5% ₹214 Cr 500,000
↓ -200,000 Zomato Ltd (Consumer Cyclical)
Equity, Since 31 Aug 24 | 5433204% ₹184 Cr 6,583,400
↑ 1,583,400 Cognizant Technology Solutions Corp Class A (Technology)
Equity, Since 31 Jul 23 | CTSH4% ₹173 Cr 254,000 Netflix Inc (Communication Services)
Equity, Since 31 Aug 21 | NFLX3% ₹150 Cr 20,000 Microsoft Corp (Technology)
Equity, Since 31 Aug 20 | MSFT3% ₹136 Cr 38,000 PB Fintech Ltd (Financial Services)
Equity, Since 30 Apr 24 | 5433903% ₹133 Cr 700,000 11. TATA India Pharma & Healthcare Fund
CAGR/Annualized return of 13.5% since its launch. Return for 2024 was 40.4% , 2023 was 36.6% and 2022 was -8% . TATA India Pharma & Healthcare Fund
Growth Launch Date 28 Dec 15 NAV (06 Jan 25) ₹31.4764 ↓ -0.33 (-1.03 %) Net Assets (Cr) ₹1,214 on 30 Nov 24 Category Equity - Sectoral AMC Tata Asset Management Limited Rating Risk High Expense Ratio 0 Sharpe Ratio 2.17 Information Ratio 0.55 Alpha Ratio 4.58 Min Investment 5,000 Min SIP Investment 150 Exit Load 0-3 Months (0.25%),3 Months and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Dec 19 ₹10,000 31 Dec 20 ₹16,438 31 Dec 21 ₹19,572 31 Dec 22 ₹17,998 31 Dec 23 ₹24,582 31 Dec 24 ₹34,513 Returns for TATA India Pharma & Healthcare Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 3 Jan 25 Duration Returns 1 Month 2.2% 3 Month 2.1% 6 Month 15.8% 1 Year 35.2% 3 Year 21.1% 5 Year 27.9% 10 Year 15 Year Since launch 13.5% Historical performance (Yearly) on absolute basis
Year Returns 2023 40.4% 2022 36.6% 2021 -8% 2020 19.1% 2019 64.4% 2018 5.5% 2017 -2.6% 2016 4.7% 2015 -14.7% 2014 Fund Manager information for TATA India Pharma & Healthcare Fund
Name Since Tenure Meeta Shetty 9 Mar 21 3.82 Yr. Rajat Srivastava 16 Sep 24 0.29 Yr. Data below for TATA India Pharma & Healthcare Fund as on 30 Nov 24
Equity Sector Allocation
Sector Value Health Care 93.55% Basic Materials 2.17% Asset Allocation
Asset Class Value Cash 4.28% Equity 95.72% Top Securities Holdings / Portfolio
Name Holding Value Quantity Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Jan 16 | SUNPHARMA12% ₹143 Cr 804,300 Aurobindo Pharma Ltd (Healthcare)
Equity, Since 30 Apr 20 | AUROPHARMA8% ₹94 Cr 741,000 Lupin Ltd (Healthcare)
Equity, Since 30 Nov 17 | LUPIN7% ₹84 Cr 410,240 Cipla Ltd (Healthcare)
Equity, Since 30 Apr 20 | CIPLA6% ₹75 Cr 490,000 Dr Reddy's Laboratories Ltd (Healthcare)
Equity, Since 31 Aug 18 | DRREDDY6% ₹74 Cr 614,555 Divi's Laboratories Ltd (Healthcare)
Equity, Since 30 Sep 17 | DIVISLAB5% ₹65 Cr 104,965 Fortis Healthcare Ltd (Healthcare)
Equity, Since 31 Oct 20 | FORTIS5% ₹56 Cr 855,100 Zydus Lifesciences Ltd (Healthcare)
Equity, Since 31 Dec 22 | ZYDUSLIFE4% ₹46 Cr 471,287 Alkem Laboratories Ltd (Healthcare)
Equity, Since 31 Aug 20 | ALKEM3% ₹42 Cr 75,249 Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 31 Dec 16 | APOLLOHOSP3% ₹40 Cr 58,903
ഇവിടെ നൽകിയിരിക്കുന്ന വിവരങ്ങൾ കൃത്യമാണെന്ന് ഉറപ്പാക്കാൻ എല്ലാ ശ്രമങ്ങളും നടത്തിയിട്ടുണ്ട്. എന്നിരുന്നാലും, ഡാറ്റയുടെ കൃത്യത സംബന്ധിച്ച് യാതൊരു ഉറപ്പും നൽകുന്നില്ല. എന്തെങ്കിലും നിക്ഷേപം നടത്തുന്നതിന് മുമ്പ് സ്കീം വിവര രേഖ ഉപയോഗിച്ച് പരിശോധിക്കുക.
AMFI Registration No. 112358 | CIN: U74999MH2016PTC282153
Shepard Technologies Pvt. Ltd. (with ARN code 112358) makes no warranties or representations, express or implied, on products offered through the platform. It accepts no liability for any damages or losses, however caused, in connection with the use of, or on the reliance of its product or related services. Terms and conditions of the website are applicable.
©2025 Shepard Technologies Private Limited. All Rights Reserved